Ernexa Therapeutics Inc.
ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31
Reports and events: 422 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2010-01-0817:20 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-10-001181 |
| 2009-11-1316:57 ET | 10-Q | Quarterly reportPeriod 2009-09-30 | 0001019687-09-004099 |
| 2009-11-1216:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001019687-09-004068 |
| 2009-09-1117:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001019687-09-003300 |
| 2009-08-2413:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001019687-09-003074 |
| 2009-08-2020:09 ET | SC 13D/A | Ownership report, active investor, amended | 0000950123-09-036925 |
| 2009-08-1415:02 ET | 10-Q | Quarterly reportPeriod 2009-06-30 | 0001019687-09-002913 |
| 2009-08-1316:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001019687-09-002852 |
| 2009-07-2316:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001019687-09-002580 |
| 2009-05-1512:16 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001019687-09-001771 |
| 2009-05-1518:00 ET | 10-Q | Quarterly reportPeriod 2009-03-31 | 0001019687-09-001751 |
| 2009-05-1416:19 ET | 8-K | 9.01 Financial statements and exhibits | 0001019687-09-001743 |
| 2009-04-3021:37 ET | DEF 14A | Proxy statementPeriod 2009-05-29 | 0001019687-09-001535 |
| 2009-04-2916:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001019687-09-001529 |
| 2009-04-2217:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-09-021900 |
| 2009-03-2420:44 ET | 10-K | Annual reportPeriod 2008-12-31 | 0001019687-09-000946 |
| 2009-03-1916:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001019687-09-000909 |
| 2009-03-1817:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-09-014906 |
| 2009-03-0316:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001019687-09-000716 |
| 2009-02-1915:59 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001019687-09-000590 |
| 2009-02-1216:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001019687-09-000474 |
| 2009-02-0419:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001019687-09-000378 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.